MedDataX Logo

Clitoral Location in Relation to Sexual Function Using Pelvic Imaging

NCT ID: NCT01195701

Last Updated: 2014-12-03

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-07-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Women who are unable to achieve orgasm compared to women who have normal orgasmic function may have different clitoral anatomy and different hormone levels. The investigators hypothesis is that women who have difficulty with orgasm may have a clitoris that is closer to the vagina and may have higher testosterone levels. Pelvic MRI will be used to observe whether clitoral measurements differ between women with normal orgasmic function vs. those with anorgasmia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women unable with anorgasmia and those with normal orgasmic function will undergo pelvic MRI so that clitoral measurements can be taken and then compared for differences.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Sexual Dysfunction Anorgasmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anorgasmia (cases)

Women with difficulty or inability to reach sexual climax will be the cases in this study.

No interventions assigned to this group

Normal orgasmic function

Women who report that they usually or always achieve sexual climax will be the controls in this study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Premenopausal female aged 18-55 years
* Sexually active (at least 1 heterosexual partner in the past 4 weeks)
* Cases must have difficulty with orgasm or be anorgasmic
* Controls must have normal sexual function

Exclusion Criteria

* Not sexually active
* Homosexual orientation
* Postmenopausal
* Stage \>2 pelvic organ prolapse (POP-Q measurements beyond hymen)
* Urinary incontinence with coitus limiting sexual activity
* Severe vaginal atrophy
* Pelvic pain/dyspareunia (
* Currently pregnant
* Depression being treated with SSRIs (depression alone or treatment of depression with non-SSRI medications is not an exclusion)
* Currently taking testosterone supplements
* History of sexual abuse
* Large pelvic mass (benign or cancerous) impeding MRI measurements or grossly abnormal pelvic anatomy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TriHealth Hatton Research Institute

OTHER

Sponsor Role collaborator

TriHealth Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christine M Vaccaro, DO

Role: PRINCIPAL_INVESTIGATOR

Good Samaritan Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Good Samaritan Hospital

Cincinnati, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10063

Identifier Type: -

Identifier Source: org_study_id